Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects with Non-segmental Vitiligo
Official title: A Randomized, Double-Blind, Vehicle-Controlled Phase 2b Trial Evaluating the Efficacy, Safety & Pharmacokinetics of VYN201 Gel in the Treatment of Non Segmental Vitiligo
Description:
The VYN201 Gel for Vitiligo clinical trial by Vyne Therapeutics Inc. is a Phase 2 study aimed at evaluating the efficacy, safety, and pharmacokinetics of VYN201 Gel in individuals with non-segmental vitiligo. Participants will apply the gel daily to affected areas over a specified period, with assessments conducted at weeks 24 and 52.
Key Details
- Study Type: Interventional (Clinical Trial)
- Phase: Phase 2
- Estimated Enrollment: Not specified
- Age Range: 18 to 75 years
- Duration: Approximately 52 weeks, including treatment and follow-up periods
Eligibility Criteria
- Adults aged 18 to 75 years
- Clinical diagnosis of non-segmental vitiligo affecting less than 10% of total body surface area
Exclusion:
- Dyed hair in treatment areas that could interfere with assessments
- Inability to maintain facial hair shorter than 5mm during the study
- Recent major surgery within the last 3 months or planned during the study period
- Pregnancy or breastfeeding
This study has 48 locations across the U.S. and Canada.
Start date: March 18, 2024
Completion date: January 30, 2026
Contact: Iain Stuart, PhD
Tel.: 1-800-775-7936
Email: clinicaltrials@vynetx.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Why Does the IRS Still Show an Old Revocation for VR Foundation?
IRS Status · A Short FAQ The old entry records the past. Publication 78 shows where VR Foundation stands today. Updated August 2026 · EIN 45-2498489 Tax records are rarely elega...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
- Any link between vitiligo and military service?
While there isn't specific research directly linking military service to the onset of vitiligo, it's critical to comprehend that vitiligo is a multifaceted disorder influenced b...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.